Home » Topics » Disease categories and therapies » Immune

Immune
RSS

GenPat77 and MedImmune sign agreement on novel therapeutic target

Oct. 5, 2004

New immunomodulators claimed for use in viral infections and cancer

Oct. 4, 2004

Kissei scientists prepare ZAP-70 and Syk kinase inhibitors for use in immune disorders

Sep. 30, 2004

Takeda researchers discover new agonists of the bile acid-responsive receptor TGR5

Sep. 29, 2004

Advisory Committee recommends approval of Menactra

Sep. 28, 2004

Enhancement of memory T-cells may improve vaccine therapies

Sep. 27, 2004

DOR BioPharma completes a pivotal trial with orBec in GvHD

Sep. 23, 2004

Acambis to submit BLA for ACAM-2000 smallpox vaccine after removal of FDA's clinical hold on trials

Sep. 22, 2004

Update on Sinovac's split flu vaccine

Sep. 22, 2004

Tacrolimus and ciclosporin equally affect glucose metabolism after pancreas transplantation

Sep. 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...